carbachol has been researched along with 3-(4-tert-butylthiazol-2-yl)methoxy)-5'-(3-(4-chlorobenzenesulfonyl)propyl-2'-(1h-tetrazol-5-ylmethoxy)benzanilide monosodium salt monohydrate in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arakida, Y; Honda, K; Miyata, K; Ohga, K; Suwa, K; Yamada, T; Yokota, M | 1 |
1 other study(ies) available for carbachol and 3-(4-tert-butylthiazol-2-yl)methoxy)-5'-(3-(4-chlorobenzenesulfonyl)propyl-2'-(1h-tetrazol-5-ylmethoxy)benzanilide monosodium salt monohydrate
| Article | Year |
|---|---|
In vitro pharmacologic profile of YM158, a new dual antagonist for LTD4 and TXA2 receptors.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Carbachol; Dinoprost; Guinea Pigs; Humans; In Vitro Techniques; Leukotriene Antagonists; Leukotriene D4; Male; Membrane Proteins; Muscle Contraction; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin D2; Receptors, Leukotriene; Receptors, Thromboxane; Tetrazoles; Thiazoles; Trachea | 1998 |